MRGN Advisors capitalizes on a unique understanding of the med tech sector in Switzerland to provide insights to investors and companies in designing innovation, partnering, financing and market access strategies.
Illustrative assignments performed recently:
Market Access optimization and pricing strategy for innovative med tech solutions with embedded IT functionalities in the fields of dermatology screening, home care and patient rehabilitation.
Develop a rapid IVD test for the detection of Celiac Disease in primary care.
Solutions and outcomes: Recommendation on the size of the opportunity and on the value of the venture, definition of the target profile of possible investors for such a venture, introduction to targeted investors for a financing round to support the commercial expansion of the company.
Complete a financing round to support the final stage of the development and the commercialization of a simple, implantable, 3-day insulin delivery device.
Solutions and outcomes: Analysis of the current and future competitive landscape, definition of the target profile of possible investors for such a venture, introduction to targeted investors for a financing round to support the advancement of the device towards regulatory approval.
Finalize the development of an E-health web service and integrated
solution supporting early skin cancer detection & skin lesion assessment by connected dermoscopy.
Analysis of the competitive landscape and of the market access strategy (including the design of a health-economic assessment), definition of the target profile of possible investors for such a venture, introduction to targeted investors for the financing round to complete the clinical validation ahead of regulatory approval.
Development and commercialization of a new generation of surgical probes based on advanced detection technology.
Analysis of the competitive profile of the probes and recommendation
regarding the market access strategy, definition of the target profile of
possible investors for such a venture, introduction to targeted investors for the financing round to leverage available real-life clinical data and complete the clinical and regulatory pathway.
Support the marketing and commercialization in Switzerland of its leading product, Pill Protect®, as well as the CE labelling of Pill Protect®.
Analysis of the competitive landscape and of the market access strategy (including the design of a cost-utility assessment), definition of the target profile of possible investors for such a venture, introduction to targeted investors for the financing round.
Development and commercialization of Vision Enhancement Systems which enable perfect vision in saturated and rapidly changing light situations, e.g. in which the naked human eye is too slow –or wrongly equipped.
Analysis of the opportunity in medical settings, of competitive landscape (including non-device-based solutions) and of the market access strategy (including the design of a clinical effectiveness cum cost-utility assessment), definition of the target profile of possible investors for such a venture, introduction to targeted investors for the financing round.
Expansion of the business opportunity for a laser-assisted technology
already used in dermatology for esthetic purposes to the epidermal delivery of immunogens of vaccines through industrial partnerships.
Analysis of the unmet medical requirements in infectious diseases and cancer vaccines administration, definition of the competitive profile and updating of the value proposition.
Introduction of the company to several potential partners in the vaccine and immunotherapy arena.
